Is a complete CSE/DRUG research report available?

Question

Accepted Answer

No complete published report is available for cse/DRUG (CSE/DRUG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	887.9M
Net income (ttm)	-24.5M
EPS (ttm)	-CA$2.86
Shares out	9.9M
Volume	600
Beta	-0.11

Metric	Value
Country	Canada
Country code	CA
Employees	26
Employees Change	25%
Employees Change Percent	2,500
Enterprise value	CAD 580.1M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA10919W4056
Last refreshed	2026-09-11
Market cap	CAD 887.9M
Price	CAD 88.71
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	cse/DRUG
Website	https://brightmindsbio.com

Metric	Value
Earnings Yield	-2.76%
P/B ratio	2.88x

Metric	Value
Net Income	CAD -24.5M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	CAD -942,646
ROA	-13.5
Roa5y	-40.07
ROCE	-12.73
ROE	-13.63
Roe5y	-69.2
ROIC	-13.61

Metric	Value
Cagr1y	56.05%
Cagr3y	217.88%
Cagr5y	20.66%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

CSE/DRUG (CSE/DRUG)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/DRUG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/DRUG indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/DRUG

Frequently asked questions

Metric	Value
Assets	CAD 310.3M
Cash	CAD 307.8M
Current Assets	CAD 310.3M
Current Liabilities	CAD 2.5M
Debt	CAD 65,589
Debt Equity	CAD 0
Equity	CAD 307.8M
Interest Coverage	-753.5
Liabilities	CAD 2.5M
Long Term Assets	CAD 52,920
Long Term Liabilities	CAD 0
Net Cash	CAD 307.8M
Net Cash By Market Cap	CAD 34.66
Net Cash Growth	500.55%
Net Debt Equity	CAD -1
Tangible Book Value	CAD 307.8M
Tangible Book Value Per Share	CAD 31.2
WACC	3.66

Metric	Value
Current ratio	122
Net Working Capital	CAD -23,186
Quick ratio	121.4
Working Capital	CAD 307.7M

Metric	Value
1Y total return	56%
200-day SMA	106.7
3Y total return	3,114.64%
50-day SMA	103.4
50-day SMA vs 200-day SMA	50under200
5Y total return	155.71%
All Time High	170
All Time High Change	-47.05%
All Time High Date	2026-01-06
All Time Low	1.29
All Time Low Change	6,877.52%
All Time Low Date	2024-04-30
ATR	3.39
Beta	-0.11
Beta1y	2.07
Beta2y	23.71
Ch YTD	-18.49
High	90.03
High52	170
High52 Date	2026-01-06
High52ch	-47.82%
Low	88.43
Low52	55.22
Low52 Date	2025-09-09
Low52ch	60.65%
Ma50ch	-12.94%
Price vs 200-day SMA	-15.65%
RSI	31.27
RSI Monthly	56.75
RSI Weekly	43.37
Sharpe ratio	1.52x
Sharpe Ratio3y	0.64x
Sortino ratio	2.77
Sortino Ratio3y	11.95
Total Return	-38.94%
Tr YTD	-18.49
Tr1m	-18.92%
Tr1w	-7.87%
Tr3m	0.52%

Metric	Value
Float	6,211,530%
Net Borrowing	-104,771
Shares Insiders	16.73%
Shares Institutions	74.53%
Shares Out	9,864,061
Shares Qo Q	2.51%
Shares Yo Y	38.94%

Metric	Value
Adjusted OCF	-29,778,583
Average Volume	603.3x
Bv Per Share	31.2
Ch1m	-18.92
Ch1w	-7.87
Ch1y	56
Ch3m	0.52
Ch3y	3,114.6
Ch5y	155.7
Ch6m	-12.36
Change	-1.44%
Change From Open	-1.47
Close	90.01
Days Gap	0.02
Depreciation Amortization	76,057
Dollar Volume	53,226
Earnings Date	2026-12-23
EBIT	CAD -39.2M
EPS	CAD -2.86
F Score	1
Financing CF	275,258,879
Fiscal Year End	September
Founded	2,017
Is Primary Listing	1
Last Earnings Date	2026-02-10
Last Report Date	2026-06-30
Last Split Date	2023-07-14
Last Split Type	Reverse
Ma150	106.7
Ma150ch	-15.63%
Ma20	103.7
Ma20ch	-13.21%
Net CF	256,440,955
Next Earnings Date	2026-12-23
Open	90.03
Position In Range	17.5
Ppne	52,920
Price Date	2026-09-10
Ptbv Ratio	2.88
Relative Volume	0.99x
Share Based Comp	5,108,086
Tr6m	-12.36%
Volume	600